Sanofi SA vs Atlassian Corporation PLC — how do they compare? Sanofi SA trades at $44.05 (market cap $104.83B), while Atlassian Corporation PLC trades at $90.58 (market cap $23.67B). The key difference: Sanofi SA is far larger — about 4.4× Atlassian Corporation PLC's market cap, and Sanofi SA pays a 5.5% dividend while Atlassian Corporation PLC pays none. Which is the better fit depends on your goals.
| SNY | TEAM | |
|---|---|---|
Market Cap | $104.83B | $23.67B |
Sector | Health | Technology |
52-Week High | $52.34 | $203.00 |
52-Week Low | $41.33 | $57.15 |
Enterprise Value | $121.32B | $23.78B |
Dividend Yield | 5.5% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →